Roche Drug Patent Portfolio

Roche owns 4 orange book drugs protected by 11 US patents Given below is the list of Roche's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5763483 Carbocyclic compounds 27 Jun, 2017 Expired
US5763483 Carbocyclic compounds 27 Dec, 2016 Expired
US5952340 Use of granisetron for the treatment of postoperative nausea and vomiting 14 Sep, 2016 Expired
US5866601 Carbocyclic compounds 02 Aug, 2016 Expired
US5866601 Carbocyclic compounds 02 Feb, 2016 Expired
US5952375 Compounds and methods for synthesis and therapy 27 Aug, 2015 Expired
US6475491 Treatment of HIV and other viral infections using combinatorial therapy 07 Jun, 2015 Expired
US5952375 Compounds and methods for synthesis and therapy 27 Feb, 2015 Expired
US6133418 Synthetic peptide inhibitors of HIV transmission 17 Nov, 2014 Expired
US5662918 Pharmaceutical agents containing diphosphonic acids and salts thereof 02 Sep, 2014 Expired
US5464933 Synthetic peptide inhibitors of HIV transmission 07 Jun, 2013 Expired


Given below is the list of recent legal activities going on the following drug patents of Roche.

Activity Date Patent Number
Patent litigations
Expire Patent 22 Apr, 2019 US7192938 (Litigated)
Maintenance Fee Reminder Mailed 05 Nov, 2018 US7192938 (Litigated)
Expire Patent 18 Jun, 2018 US7718634 (Litigated)
Maintenance Fee Reminder Mailed 01 Jan, 2018 US7718634 (Litigated)
Expire Patent 09 Sep, 2016 US7410957 (Litigated)
Recordation of Patent Grant Mailed 18 May, 2010 US7718634 (Litigated)
Patent Issue Date Used in PTA Calculation 18 May, 2010 US7718634 (Litigated)
Issue Notification Mailed 28 Apr, 2010 US7718634 (Litigated)
Dispatch to FDC 14 Apr, 2010 US7718634 (Litigated)
Application Is Considered Ready for Issue 14 Apr, 2010 US7718634 (Litigated)
Issue Fee Payment Received 01 Apr, 2010 US7718634 (Litigated)
Issue Fee Payment Verified 01 Apr, 2010 US7718634 (Litigated)
Mail Miscellaneous Communication to Applicant 01 Apr, 2010 US7718634 (Litigated)
Miscellaneous Communication to Applicant - No Action Count 29 Mar, 2010 US7718634 (Litigated)
Information Disclosure Statement considered 25 Mar, 2010 US7718634 (Litigated)


Roche's Drug Patent Litigations

Roche's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Apr 23, 1999, against patent number US5464933. The petitioner , challenged the validity of this patent, with BOLOGNESI as the respondent. Click below to track the latest information on how companies are challenging Roche's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US5464933 April, 1999 Decision
(23 Apr, 1999)
BOLOGNESI


Roche's Family Patents


Family Patents



Roche Drug List

Given below is the complete list of Roche's drugs and the patents protecting them.


1. Boniva

Boniva is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5662918 Pharmaceutical agents containing diphosphonic acids and salts thereof 02 Sep, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Boniva's drug page


2. Fuzeon

Fuzeon is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6475491 Treatment of HIV and other viral infections using combinatorial therapy 07 Jun, 2015
(9 years ago)
Expired
US6133418 Synthetic peptide inhibitors of HIV transmission 17 Nov, 2014
(9 years ago)
Expired
US5464933 Synthetic peptide inhibitors of HIV transmission 07 Jun, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fuzeon's drug page


3. Kytril

Kytril is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5952340 Use of granisetron for the treatment of postoperative nausea and vomiting 14 Sep, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Kytril's drug page


4. Tamiflu

Tamiflu is protected by 6 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5763483
(Pediatric)
Carbocyclic compounds 27 Jun, 2017
(7 years ago)
Expired
US5763483 Carbocyclic compounds 27 Dec, 2016
(7 years ago)
Expired
US5866601
(Pediatric)
Carbocyclic compounds 02 Aug, 2016
(8 years ago)
Expired
US5866601 Carbocyclic compounds 02 Feb, 2016
(8 years ago)
Expired
US5952375
(Pediatric)
Compounds and methods for synthesis and therapy 27 Aug, 2015
(9 years ago)
Expired
US5952375 Compounds and methods for synthesis and therapy 27 Feb, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tamiflu's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Roche News

European healthcare industry experiences significant drop in stock prices due to worries related to Novo Nordisk and AstraZeneca.

11 Oct, 2024

FDA in the United States Approves Two Biosimilars for Popular Eye Medication Eylea

11 Oct, 2024

Information on Ozempic and Wegovy, prescription medications for weight loss: A comprehensive guide - Quartz

09 Oct, 2024

Roche Expedited Development of Obesity Medication, Targets Potential Sales of Over $3 Billion

30 Sep, 2024

See More